vs

Side-by-side financial comparison of LendingClub Corp (LC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $252.3M, roughly 2.0× LendingClub Corp). LendingClub Corp runs the higher net margin — 20.5% vs 6.8%, a 13.6% gap on every dollar of revenue. On growth, LendingClub Corp posted the faster year-over-year revenue change (15.9% vs -1.7%). Over the past eight quarters, LendingClub Corp's revenue compounded faster (16.1% CAGR vs -0.1%).

LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

LC vs MD — Head-to-Head

Bigger by revenue
MD
MD
2.0× larger
MD
$493.8M
$252.3M
LC
Growing faster (revenue YoY)
LC
LC
+17.6% gap
LC
15.9%
-1.7%
MD
Higher net margin
LC
LC
13.6% more per $
LC
20.5%
6.8%
MD
Faster 2-yr revenue CAGR
LC
LC
Annualised
LC
16.1%
-0.1%
MD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LC
LC
MD
MD
Revenue
$252.3M
$493.8M
Net Profit
$51.6M
$33.7M
Gross Margin
Operating Margin
9.9%
Net Margin
20.5%
6.8%
Revenue YoY
15.9%
-1.7%
Net Profit YoY
341.0%
10.5%
EPS (diluted)
$0.44
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LC
LC
MD
MD
Q1 26
$252.3M
Q4 25
$266.5M
$493.8M
Q3 25
$266.2M
$492.9M
Q2 25
$248.4M
$468.8M
Q1 25
$217.7M
$458.4M
Q4 24
$217.2M
$502.4M
Q3 24
$201.9M
$511.2M
Q2 24
$187.2M
$504.3M
Net Profit
LC
LC
MD
MD
Q1 26
$51.6M
Q4 25
$33.7M
Q3 25
$44.3M
$71.7M
Q2 25
$38.2M
$39.3M
Q1 25
$11.7M
$20.7M
Q4 24
$30.5M
Q3 24
$14.5M
$19.4M
Q2 24
$14.9M
$-153.0M
Operating Margin
LC
LC
MD
MD
Q1 26
Q4 25
18.8%
9.9%
Q3 25
21.5%
13.8%
Q2 25
21.7%
12.8%
Q1 25
7.2%
7.0%
Q4 24
5.1%
7.8%
Q3 24
8.9%
6.6%
Q2 24
10.4%
-31.3%
Net Margin
LC
LC
MD
MD
Q1 26
20.5%
Q4 25
6.8%
Q3 25
16.6%
14.5%
Q2 25
15.4%
8.4%
Q1 25
5.4%
4.5%
Q4 24
6.1%
Q3 24
7.2%
3.8%
Q2 24
8.0%
-30.3%
EPS (diluted)
LC
LC
MD
MD
Q1 26
$0.44
Q4 25
$0.36
$0.40
Q3 25
$0.37
$0.84
Q2 25
$0.33
$0.46
Q1 25
$0.10
$0.24
Q4 24
$0.08
$0.37
Q3 24
$0.13
$0.23
Q2 24
$0.13
$-1.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LC
LC
MD
MD
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$1.5B
$865.9M
Total Assets
$11.9B
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LC
LC
MD
MD
Q1 26
Q4 25
$375.2M
Q3 25
$340.1M
Q2 25
$224.7M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Total Debt
LC
LC
MD
MD
Q1 26
Q4 25
$0
$570.5M
Q3 25
$0
$577.2M
Q2 25
$0
$583.9M
Q1 25
$0
$590.5M
Q4 24
$0
$597.1M
Q3 24
Q2 24
Stockholders' Equity
LC
LC
MD
MD
Q1 26
$1.5B
Q4 25
$1.5B
$865.9M
Q3 25
$1.5B
$890.7M
Q2 25
$1.4B
$833.8M
Q1 25
$1.4B
$789.2M
Q4 24
$1.3B
$764.9M
Q3 24
$1.3B
$732.5M
Q2 24
$1.3B
$706.5M
Total Assets
LC
LC
MD
MD
Q1 26
$11.9B
Q4 25
$11.6B
$2.2B
Q3 25
$11.1B
$2.2B
Q2 25
$10.8B
$2.1B
Q1 25
$10.5B
$2.0B
Q4 24
$10.6B
$2.2B
Q3 24
$11.0B
$2.1B
Q2 24
$9.6B
$2.0B
Debt / Equity
LC
LC
MD
MD
Q1 26
Q4 25
0.00×
0.66×
Q3 25
0.00×
0.65×
Q2 25
0.00×
0.70×
Q1 25
0.00×
0.75×
Q4 24
0.00×
0.78×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LC
LC
MD
MD
Operating Cash FlowLast quarter
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LC
LC
MD
MD
Q1 26
Q4 25
$-2.7B
$114.1M
Q3 25
$-770.8M
$137.3M
Q2 25
$-713.1M
$137.2M
Q1 25
$-339.3M
$-117.5M
Q4 24
$-2.6B
$133.0M
Q3 24
$-669.8M
$91.8M
Q2 24
$-932.5M
$107.0M
Free Cash Flow
LC
LC
MD
MD
Q1 26
Q4 25
$-2.9B
Q3 25
$-791.8M
Q2 25
$-803.8M
Q1 25
$-352.3M
Q4 24
$-2.7B
Q3 24
$-682.3M
Q2 24
$-945.3M
FCF Margin
LC
LC
MD
MD
Q1 26
Q4 25
-1076.0%
Q3 25
-297.4%
Q2 25
-323.5%
Q1 25
-161.8%
Q4 24
-1237.8%
Q3 24
-338.0%
Q2 24
-504.9%
Capex Intensity
LC
LC
MD
MD
Q1 26
Q4 25
52.7%
Q3 25
7.9%
Q2 25
36.5%
Q1 25
6.0%
Q4 24
25.0%
Q3 24
6.2%
Q2 24
6.9%
Cash Conversion
LC
LC
MD
MD
Q1 26
Q4 25
3.39×
Q3 25
-17.41×
1.91×
Q2 25
-18.68×
3.49×
Q1 25
-29.07×
-5.66×
Q4 24
4.36×
Q3 24
-46.33×
4.72×
Q2 24
-62.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LC
LC

Segment breakdown not available.

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons